Abstract
The inclusion of vanadocene dichloride (VDC) and 1,1′-dimethyl vanadocene dichloride (MeVDC) into cyclodextrines (α-CD, β-CD and γ-CD) was studied by EPR spectroscopy. It was found that VDC and MeVDC with β-CD and γ-CD form true inclusion compounds, but with α-CD, VDC and MeVDC gave only fine dispersion mixtures. The inclusion was validated by anisotropic EPR spectra of solid samples. In addition, the antimicrobial was validated by anisotropic EPR spectra of solid samples. In addition, the antimicrobial behavior (against E. coli) of each of the complexes was determined. It was established that not only did VDC and MeVDC cause elongation of E. coli, but also the new vanadocene inclusion complexes were effective in this regard.
[1] V.J. Moebus, R. Stein, D.G. Kieback, I.B. Runnebaum, G. Sass and R. Kreienberg: “Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives”, Anticancer Research, Vol. 17, (1997), pp. 815–821. Search in Google Scholar
[2] G. Lümmen, H. Sperling, H. Luboldt, T. Otto and H. Rübben: “Phase II trial of titanocene dichloride in advanced renal-cell carcinoma”, Cancer Chemother. Pharmacol., Vol. 42, (1998), pp. 415–417. http://dx.doi.org/10.1007/s00280005083810.1007/s002800050838Search in Google Scholar
[3] P. Köpf-Maier: “Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma”, Anticancer Research, Vol. 19, (1999), pp. 493–504. Search in Google Scholar
[4] N. Kroger, U.R. Kleeberg, K. Mross, L. Edler, G. Sass and D.K. Hossfeld: “Phase II clinical trial of titanocene dichloride in patients with metastatic breast cancer”, Onkologic, Vol. 23, (2000), pp. 60–62. http://dx.doi.org/10.1159/00002707510.1159/000027075Search in Google Scholar
[5] P. Köpf-Maier and H. Köpf: “Non-Platinum-Group Metal Antitumor Agents: History, Current Status, and Perspectives”, Chem. Rev., Vol. 87, (1987), pp. 1137–1152. http://dx.doi.org/10.1021/cr00081a01210.1021/cr00081a012Search in Google Scholar
[6] A. Harada and S. Takahashi: “Preparation and Properties of Cyclodextrin-Ferrocene Inclusion Complexes”, J. Chem. Soc.-Chem. Commun. (1984), pp. 645–646. Search in Google Scholar
[7] A. Harada, Y. Hu, S. Yamamoto and S. Takahashi: “Preparation and Properties of Inclusion-Compounds of Ferrocene and Its Derivatives with Cyclodextrins”, J. Chem. Soc.-Dalton Trans., (1988), pp. 729–732. Search in Google Scholar
[8] Y. Odagaki, K. Hirotsu, T. Higuchi, A. Harada and S. Takahashi: “X-Ray Structure of the α-Cyclodextrin Ferrocene (2-1) Inclusion Compound”, J. Chem. Soc.-Perkin Trans. 1, (1990), pp. 1230–1231. http://dx.doi.org/10.1039/p1990000123010.1039/P19900001230Search in Google Scholar
[9] P. Ferreira, I.S. Goncalves, M. Pillinger, J. Rocha, P. Santos and J.J.C. Teixeira-Dias: “Modification of β-cyclodextrin with ferrocenyl groups by ring opening of an encapsulated 1 ferrocenophane”, Organometallics, Vol. 19 (2000), pp. 1455–1457. http://dx.doi.org/10.1021/om991033u10.1021/om991033uSearch in Google Scholar
[10] S.S. Braga, I.S. Goncalves, A.D. Lopes, M. Pillinger, J. Rocha, C.C. Romao and J.J.C. Teixeira-Dias: “Encapsulation of half-sandwich complexes of molybdenum with beta-cyclodextrin”, J. Chem. Soc-Dalton Trans., (2000), pp. 2964–2968. Search in Google Scholar
[11] S. Lima, I.S. Goncalves, P. Ribeiro-Claro, M. Pillinger, A.D. Lopes, P. Ferreira J.J.C. Teixeira-Dias, J. Rocha and C.C. Romao: “Interactions of cationic and neutral molybdenum complexes with β-cyclodextrin host molecules”, Organometallics, Vol. 20 (2001), pp. 2191–2197. http://dx.doi.org/10.1021/om001088s10.1021/om001088sSearch in Google Scholar
[12] I. Turel, A. Demsar and J. Kosmrlj: “The interactions of titanocene dihalides with alpha-, beta- and gamma-cyclodextrin host molecules”, J. Incl. Phenom. Macrocycl. Chem., Vol. 35, (1999), pp. 595–604. http://dx.doi.org/10.1023/A:100802671596410.1023/A:1008026715964Search in Google Scholar
[13] C.S. Lu, Y. Zou, J.L. Xie, Z.P. Ni, H.Z. Zhu, Q.J. Meng and Y.G. Yao: “An antitumor agent of β-cyclodextrin-modified titanocene complex: Synthesis and characterization”, Chem. Pharm. Bull., Vol. 51 (2003), pp. 864–866. http://dx.doi.org/10.1248/cpb.51.86410.1248/cpb.51.864Search in Google Scholar
[14] S.S. Braga, I.S. Gonçalves, M. Pillinger, P. Ribeiro-Claro and J.J.C. Teixeira-Dias: “Experimental and theoretical study of the interaction of molybdenocene dichloride (Cp2MoCl2) with β-cyclodextrin”, J. Organomet. Chem., Vol. 632, (2001), pp. 11–16. http://dx.doi.org/10.1016/S0022-328X(01)00836-110.1016/S0022-328X(01)00836-1Search in Google Scholar
[15] E. Fenyvesi, L. Szente, N.R. Russell and M. McNamara: Comprehensive Supramolecular Chemistry, J.L. Atwood, J.E.D. Davies, D.D. MacNicol, F. Vögtle, J.M. Lehn, J. Szejtli and T. Osa (Eds.), Pergamon, Oxford, 1996, Vol. 3, chap. 10. Search in Google Scholar
[16] I. Pavlík and J. Vinklárek: “Hydrolysis Behavior of the Antitumor Agent Vanadocene Dichloride in Strongly Acid, Neutral and Alkaline Aqueous-Media-an EPR Study”, Eur. J. Solid State Inorg. Chem., Vol. 28, (1991), pp. 815–827. Search in Google Scholar
[17] J. Honzíček, P. Nachtigall, I. Císařova and J. Vinklárek: “Synthesis, characterization and structural investigation of the first vanadocene(IV) carboxylic acid complexes prepared from the vanadocene dichloride”, J. Organomet. Chem., Vol. 689, (2004), pp. 1180–1187. http://dx.doi.org/10.1016/j.jorganchem.2003.11.04210.1016/j.jorganchem.2003.11.042Search in Google Scholar
[18] B. Rosenberg and L. van Camp: “The inhibition of grwoth and cell division in Escherichia coli)”, J. Biol. Chem., Vol. 242, (1967), pp. 1347–1352. Search in Google Scholar
[19] I.C. Tornieporth-Oetting and P.S. White: “Ionic Titanocene(IV) α-Amino-Acid Complexes of Dl- Phenylalanine and Dl-4-Fluorophenylalanine-Synthesis, Characterization, and Investigation of the Antimicrobial Behavior toward Escherichia-Coli”, Organometallics, Vol. 14, (1995), pp. 1632–1636. http://dx.doi.org/10.1021/om00004a01710.1021/om00004a017Search in Google Scholar
[20] E. Diana, R. Rossetti, P.L. Stanghellini and S.F.A. Kettle: “Vibrational study of (η 5-cyclopentadienyl) metal complexes”, Inorg. Chem., Vol. 36, (1997), pp. 382–391. http://dx.doi.org/10.1021/ic960545n10.1021/ic960545nSearch in Google Scholar
[21] J. Petersen and F. Dahl: “Synthesis and Structural Characterization by X-Ray Diffraction and Electron Paramagetic Resonance Single-Crystal Techniques of V(η 5-C5H4CH3)2Cl2 and Ti(η 5-C5H4CH3)2Cl2. A Study of the Distribution of the Unpaired Electron in a V(η 5-C5H5)2L2-Type Complex”, J. Am. Chem. Soc., Vol. 97, (1975), pp. 6422–6233. http://dx.doi.org/10.1021/ja00855a02210.1021/ja00855a022Search in Google Scholar
[22] P. Gowik and T. Klapötke: “Why Do Organometallic Hexafluoropnicogenate Complexes Show Biocidal Activity-a Study to the Structure Activity Correlation”, Monatshefte Für Chemie, Vol. 120, (1989), pp. 711–714. http://dx.doi.org/10.1007/BF0080996210.1007/BF00809962Search in Google Scholar
[23] K. Mross, P. Robben-Bathe, L. Edler, J. Baumgart, W.E. Berdel, H. Fiebig and C. Unger: “Phase I clinical trial of a day-1,-3,-5 every 3 weeks schedule with titanocene dichloride (MKT 5) in patients with advanced cancer-A study of the phase I study group of the Association for Medical Oncology (AIO) of the German Cancer Society”, Onkologie, Vol. 23, (2000), pp. 576–579. http://dx.doi.org/10.1159/00005500910.1159/000055009Search in Google Scholar PubMed
[24] G. Wilkinson and J.M. Birmingham: “Bis-Cyclopentadienyl Compounds of Ti, Zr, V, Nb and Ta”, J. Am. Chem. Soc., Vol. 76, (1954), p. 4281. http://dx.doi.org/10.1021/ja01646a00810.1021/ja01646a008Search in Google Scholar
[25] J. Krzystek, A. Sienkiewicz, L. Pardi and L.C. Brunel: “DPPH as a Standard for High-Field EPR”, J. Magn. Reson., Vol. 125, (1997), pp. 207–211. http://dx.doi.org/10.1006/jmre.1996.109810.1006/jmre.1996.1098Search in Google Scholar PubMed
© 2005 Versita Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
